STRS Ohio’s Orexigen Therapeutics, Inc. OREX Stock Holding History

STRS Ohio’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-419	Closed	-$26K	–	1943
2013 Q3	$26K	Hold	419	–	–	﹤0.01%	1779
2013 Q2	$25K	Buy	+419	New	+$25.8K	﹤0.01%	1792

Other funds holding OREX

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's OREX Position: Q4 2013 in Review

STRS Ohio sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2013, closing a stake of 419 shares — an estimated $26K sold.

STRS Ohio first reported a position in OREX in Q2 2013 and held it in 2 quarters. The position peaked at $26K in Q3 2013. 124 funds tracked by Wall St. Rank hold OREX as of Q4 2013.

STRS Ohio reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2013 after selling out during the quarter.
STRS Ohio sold 419 Orexigen Therapeutics, Inc. shares in Q4 2013, an estimated $26K.
STRS Ohio first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 2 quarters.
STRS Ohio's Orexigen Therapeutics, Inc. position peaked at $26K in Q3 2013.
124 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2013.

Based on STRS Ohio's 13F filing for Q4 2013, filed 30 Jan 2014.